The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United.

Blood Cancer United is an evolution—not a new beginning—that will help us meet our bold goal: to enable patients with blood cancer to gain more than one million years of life by 2040.

With the name Blood Cancer United, we can now reach more people who need us—people affected by all 100+ types of blood cancer.

Our mission is not changing. And we will continue to be a global leader in blood cancer—research, support, and advocacy.

Our organizational strategy: Extending and improving lives

Since we began in 1949, we’ve made tremendous strides for the blood cancer community. Some blood cancers can now be cured, and others can be managed as long-term chronic conditions. So, we measure our progress not just by cures, but by all the people who can live longer, more active lives after a blood cancer diagnosis.

We do this by:

• Looking for the new ideas, funding the science, and bringing together the necessary elements, experts, and innovations to help accelerate progress
• Protecting access to high-quality, affordable health coverage and funding for vital research into new, better treatments
• Providing support to new and existing patients, survivors, caregivers, and healthcare professionals
• Developing and implementing novel programmatic and research efforts that focus on survivorship, caregiving, clinical trials, equitable access to care, and quality of life